{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:45:24Z","timestamp":1774385124031,"version":"3.50.1"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.4339","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T15:01:48Z","timestamp":1588863708000},"page":"e204339","source":"Crossref","is-referenced-by-count":17,"title":["Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis"],"prefix":"10.1001","volume":"3","author":[{"given":"Lindsey B.","family":"De Lott","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"},{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Burke","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris A.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Costello","sequence":"additional","affiliation":[{"name":"Section of Ophthalmology, Department of Clinical Neurosciences and Surgery, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne T.","family":"Cornblath","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Trobe","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"},{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin A.","family":"Kerber","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"issue":"9","key":"zoi200214r1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis.","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi200214r2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archopht.126.7.994","article-title":"Treatment of acute optic neuritis: a summary of findings from the Optic Neuritis Treatment Trial.","volume":"126","author":"Beck","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"zoi200214r3","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis: experience of the Optic Neuritis Treatment Trial.","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"issue":"11","key":"zoi200214r4","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1212\/WNL.54.11.2039","article-title":"Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis: report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"54","author":"Kaufman","year":"2000","journal-title":"Neurology"},{"issue":"1-2","key":"zoi200214r5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2008.08.039","article-title":"Management of optic neuritis and impact of clinical trials: an international survey.","volume":"276","author":"Biousse","year":"2009","journal-title":"J Neurol Sci"},{"issue":"2","key":"zoi200214r6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial.","volume":"14","author":"Cleary","year":"1993","journal-title":"Control Clin Trials"},{"key":"zoi200214r7","doi-asserted-by":"publisher","first-page":"h1302","DOI":"10.1136\/bmj.h1302","article-title":"Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks.","volume":"350","author":"Spertus","year":"2015","journal-title":"BMJ"},{"issue":"8","key":"zoi200214r9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi200214r10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/(ISSN)1531-8249","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols.","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"issue":"1","key":"zoi200214r11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT).","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"zoi200214r12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","article-title":"Proper method for calculating average visual acuity.","volume":"13","author":"Holladay","year":"1997","journal-title":"J Refract Surg"},{"issue":"6","key":"zoi200214r14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1212\/01.wnl.0000267272.60714.42","article-title":"Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome.","volume":"69","author":"Kupersmith","year":"2007","journal-title":"Neurology"},{"issue":"16","key":"zoi200214r15","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1001\/jama.1993.03500160080036","article-title":"Side effects of glucocorticoid treatment: experience of the Optic Neuritis Treatment Trial.","volume":"269","author":"Chrousos","year":"1993","journal-title":"JAMA"},{"issue":"6","key":"zoi200214r16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1001\/jamaneurol.2018.0024","article-title":"Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial.","volume":"75","author":"Morrow","year":"2018","journal-title":"JAMA Neurol"},{"key":"zoi200214r17","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"zoi200214r18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jnnp-2019-321653","article-title":"Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence.","volume":"91","author":"Petzold","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"zoi200214r19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"zoi200214r8","unstructured":"Journal of Applied Economics and Business Studies. Accessed March 31, 2020. http:\/\/www.jaebs.com"},{"key":"zoi200214r13","unstructured":"World Health Organization. Blindness and vision impairment. Published October 8, 2019. Accessed March 31, 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2765658\/de_lott_2020_oi_200214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T07:28:05Z","timestamp":1666510085000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2765658"}},"subtitle":["Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.4339","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]}}}